Emergent BioSolutions Inc reaffirms FY 2013 guidance


Wednesday, 11 Dec 2013 06:40pm EST 

Emergent BioSolutions Inc:Says reaffirmed FY 2013 GAAP guidance for total revenues of $300 to $310 million and net income of $25 to $30 million.Says excluding about $7 million in estimated transaction-related and other costs incurred in the current year, the company is providing a forecast for FY 2013 non-GAAP adjusted net income of $30 to $35 million.FY 2013 revenue of $308 mln and net income of $30 mln - Thomson Reuters I/B/E/S Estimates. 

Company Quote

24.56
0.3 +1.24%
21 Nov 2014